Soy, estrogen, and endometriosis: bridging nutritional research with clinical practice

Howard S; Shelby Howard; Siobhán Howard; Laurel Stadtmauer; Stadtmauer L

doi:10.1016/j.fertnstert.2025.09.008

Soy, estrogen, and endometriosis: bridging nutritional research with clinical practice

Howard S, Shelby Howard, Siobhán Howard, Laurel Stadtmauer, Stadtmauer L

Fertility and sterility · 2025 · vol. 124(5) , pp. 994–995 · doi:10.1016/j.fertnstert.2025.09.008 · PMID:40939711 · W4414105648

Other OA: closed CC0

🔓 Open OA copy View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-11 ⓘ

This paper explores the relationship between soy consumption, estrogen's role, and endometriosis, aiming to connect nutritional research findings with clinical applications.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis 2018

References (3)

Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis via openalex
doi:10.1093/jn/133.3.956s via openalex
doi:10.3390/nu8060361 via openalex

Source provenance

europepmc: last seen: 2026-11-04T06:09:08.831786+00:00
openalex: last seen: 2026-05-11T06:24:00.257642+00:00
pubmed: last seen: 2026-11-04T06:04:28.079579+00:00
unpaywall: last seen: 2026-10-29T06:31:18.914191+00:00

License: CC0 · commercial use OK

[1] Daidzein-rich isoflavone aglycones inhibit cell growth and inflammation in endometriosis 2018